Skip to main content
Fig. 1 | BMC Family Practice

Fig. 1

From: Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial

Fig. 1

Workflow IDrug study. Each GP provides a list of all patients meeting the inclusion criteria. The order of patient enrollment is random. Following randomization to a study arm, the patients receive either a standardized or an individualized risk assessment leaflet and are followed up for 9 months. 870 patients will be required, and considering an estimated dropout rate of 10 % 960 patients need to be included. At the end of the study, both groups will be compared regarding primary and secondary endpoints

Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us